Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
June 26, 2015

Recent Stories of Interest

From Drug Benefit News - An FDA advisory committee this month gave its early blessing on two potentially game-changing agents in a new class of cholesterol-lowering drugs known as PCSK9 inhibitors. Even though the first of the drugs is not likely to be approved until late July, Express Scripts Holding Co. has already begun articulating its strategy to address the injectable agents, which are expected to come to market at a premium price. And other PBMs are likely to follow suit with negotiation strategies that industry observers say will mirror the entry of two high-cost hepatitis C agents in late 2014. Read more

As sponsors of qualified health plans (QHPs) fine-tune their product offerings for… Read more

At its 2015 Outcomes Symposium held last month for clients in Buena… Read more

Three years after SXC Health Solutions Corp. purchased Catalyst Health Solutions, Inc.… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

June 25, 2015
Rite Aid Closes on EnvisionRx Deal

Rite Aid finalized its acquisition of pharmacy benefit manager EnvisionRx.

June 19, 2015
Generic Copaxone Finally Launches

Court of Appeals invalidates Copaxone patent; Teva launches generic Glatopa at reported 15% discount

June 4, 2015
Catamaran Faces Suit Over United Deal

A class-action suit accuses Catamaran of misleading shareholders regarding a proposed UnitedHealth transaction.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?